Abstract
Prospective longevity is overshadowed by the high prevalence of mental decline in aging. Hence, nutritional indications are a crucial element in todays observed aging of the population. There is now growing epidemiological evidence suggesting that reduced levels of docosahexaenoic acid [DHA, 22:6, (n-3)] may be indicative of an increased risk of Alzheimers disease (AD). On the other hand, the Mediterranean diet includes high intake of fatty fish and has been associated with lower AD risk; fish is the major food source of DHA. Recently three new families of DHA-derived mediators - termed D series resolvins (RvDs, 17S epimers), protectins (NPDs, 17S epimers) and maresins - have been uncovered; these new bioactive lipids confer potent cellular protection. In the presence of aspirin (ASA), equipotent ASA-triggered 17R epimers (ASA-RvDs and ASA-NPDs) were produced in vivo. However, while enzymatic oxidation dramatically reduced the bioactivity of 17S epimers RvDs and NPDs, enzymatic conversion of ASA-17R epimers was sharply reduced. Specifically, as ASA-DHA-derived lipids have cellular protective actions, the resistance to rapid inactivation may contribute to the beneficial actions of omega-3 (n-3) fish oils and ASA in humans and offers new insights into the prevention of neurodegenerative diseases.
Keywords: Alzheimer's disease, aspirin, DHA, EPA, maresin, neuroprotectin, resolvin, docosahexaenoic acid, maresins, inter alia, eicosapen-taenoic acid, n-3, ApoE4 genotype, rotoxins, methylmercury, microcephaly, cerebral palsy, institutional boilers, chlo-rine production, waste incineration, oceans - bio-concentrate, sporadic, vitro nitrosamine, neurodegeneration, cadaverine, biogenic amine, amyloid, beta amyloid, amy-loidosis, DHA-oxygenation pathways, ASA-generated, acetylating COX-2, COX, arachidonic acid (ARA), resolvins, protect-ins, neuroprotectin D1 (NPD1, neurite growth, A pep-tide, brain-derived neurotrophic factor, superoxide dismutase-1, catalase, Reactive oxygen species, catecholamine synthesis, n-3 family, PUFAs, glial cells, astro-cytes, BDNF protein
Current Nutrition & Food Science
Title: Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease
Volume: 6 Issue: 4
Author(s): Massimo F.L. Pomponi, Massimiliano Pomponi and Giovanni Gambassi
Affiliation:
Keywords: Alzheimer's disease, aspirin, DHA, EPA, maresin, neuroprotectin, resolvin, docosahexaenoic acid, maresins, inter alia, eicosapen-taenoic acid, n-3, ApoE4 genotype, rotoxins, methylmercury, microcephaly, cerebral palsy, institutional boilers, chlo-rine production, waste incineration, oceans - bio-concentrate, sporadic, vitro nitrosamine, neurodegeneration, cadaverine, biogenic amine, amyloid, beta amyloid, amy-loidosis, DHA-oxygenation pathways, ASA-generated, acetylating COX-2, COX, arachidonic acid (ARA), resolvins, protect-ins, neuroprotectin D1 (NPD1, neurite growth, A pep-tide, brain-derived neurotrophic factor, superoxide dismutase-1, catalase, Reactive oxygen species, catecholamine synthesis, n-3 family, PUFAs, glial cells, astro-cytes, BDNF protein
Abstract: Prospective longevity is overshadowed by the high prevalence of mental decline in aging. Hence, nutritional indications are a crucial element in todays observed aging of the population. There is now growing epidemiological evidence suggesting that reduced levels of docosahexaenoic acid [DHA, 22:6, (n-3)] may be indicative of an increased risk of Alzheimers disease (AD). On the other hand, the Mediterranean diet includes high intake of fatty fish and has been associated with lower AD risk; fish is the major food source of DHA. Recently three new families of DHA-derived mediators - termed D series resolvins (RvDs, 17S epimers), protectins (NPDs, 17S epimers) and maresins - have been uncovered; these new bioactive lipids confer potent cellular protection. In the presence of aspirin (ASA), equipotent ASA-triggered 17R epimers (ASA-RvDs and ASA-NPDs) were produced in vivo. However, while enzymatic oxidation dramatically reduced the bioactivity of 17S epimers RvDs and NPDs, enzymatic conversion of ASA-17R epimers was sharply reduced. Specifically, as ASA-DHA-derived lipids have cellular protective actions, the resistance to rapid inactivation may contribute to the beneficial actions of omega-3 (n-3) fish oils and ASA in humans and offers new insights into the prevention of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
F.L. Pomponi Massimo, Pomponi Massimiliano and Gambassi Giovanni, Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease, Current Nutrition & Food Science 2010; 6 (4) . https://dx.doi.org/10.2174/157340110793663680
DOI https://dx.doi.org/10.2174/157340110793663680 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Sensory-Dependent Knowledge in Young and Elderly Adults: Argument from the Cross-Modal Priming Effect
Current Aging Science Review of 5-HT4R Ligands: State of Art and Clinical Applications
Current Topics in Medicinal Chemistry HIV-1 Latency and Eradication: Past, Present and Future
Current HIV Research Association and Causal Relationship of Midlife Obesity and Related Metabolic Disorders with Old Age Cognition
Current Alzheimer Research Treatment of Hypertensive Left Ventricular Hypertrophy
Current Pharmaceutical Design Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer’s Disease: An LC-MS/MS-based Metabolomics Analysis
Current Alzheimer Research Other Proteins Involved in Parkinson's Disease and Related Disorders
Current Protein & Peptide Science Dorsal Stream Dysfunction in Children. A Review and an Approach to Diagnosis and Management
Current Pediatric Reviews Treatment of Mild Cognitive Impairment (MCI)
Current Alzheimer Research Treatment of Chronic Myeloid Leukemia Elderly Patients in the Tyrosine Kinase Inhibitor Era
Current Cancer Drug Targets Diffusion Tensor Imaging to Determine Effects of Antidementive Treatment on Cerebral Structural Connectivity in Alzheimer’s Disease
Current Pharmaceutical Design Increase of EEG Alpha3/Alpha2 Power Ratio Detects Inferior Parietal Lobule Atrophy in Mild Cognitive Impairment
Current Alzheimer Research Quetiapine Modulates Conditioned Anxiety and Alternation Behavior in Alzheimer’s Transgenic Mice
Current Alzheimer Research In Silico Screening of Drugs to Find Potential Gamma-Secretase Inhibitors Using Pharmacophore Modeling, QSAR and Molecular Docking Studies
Combinatorial Chemistry & High Throughput Screening Neurotoxicity of β-Amyloid Protein: Oligomerization, Channel Formation and Calcium Dyshomeostasis
Current Pharmaceutical Design “Tripping out” with the TRP Superfamily and TRPV1 for Novel Neuroprotection
Current Neurovascular Research Editorial [Hot Topic: Advances in Alzheimer Therapy: Development of Innovative New Strategies (Guest Editors: Nigel H. Greig, Ezio Giacobini and Debomoy K. Lahiri)]
Current Alzheimer Research Design, Synthesis and Biological Evaluation of Scutellarein Derivatives as Potential Anti-Alzheimers Disease Candidates Based on Metabolic Mechanism
Letters in Drug Design & Discovery The Impact of Pharmaceutical Care Practice on the Practitioner and the Patient in the Ambulatory Practice Setting: Twenty-five Years of Experience
Current Pharmaceutical Design Neurodegeneration and Neurogenesis: Focus on Alzheimers Disease
Current Alzheimer Research